ArticleFrontiers in pharmacology2026

Immune checkpoint inhibitors and myocarditis-myositis-myasthenia gravis overlap: a FAERS pharmacovigilance study with time-to-onset characterization.

Burak Pacaci et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.